Abo Blood-Groups and Cancer

Hartmann, Olivier; Stavem, P

doi:10.1016/s0140-6736(64)91696-4

Cited by 19 publications

(12 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The distribution of ABO blood groups in gastric adenocarcinoma patients shown in our study was totally different with the previous reports from the western countries [12,16,[18][19][20]. In Table 3, we compared the condition of ABO blood group distribution of gastric cancer in different areas.…”

Section: Discussioncontrasting

confidence: 90%

A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China

et al. 2010

View full text Add to dashboard Cite

Little is known about the relationship between ABO blood groups and the clinicopathologic features in gastric adenocarcinoma patients of China. Whether the distribution of ABO blood groups in patients with gastric adenocarcinoma differs from that with benign diseases is also unknown. A total of 474 gastric adenocarcinoma patients and 404 with benign diseases were enrolled for the study. The relationship between patients' ABO blood groups and the clinicopathologic features was analyzed. The percentage of blood group AB was more common in men of gastric cancer than in benign diseases. The proportion of angiolymphatic invasion among patients with blood group O was significantly lower than those with other blood groups (P = 0.034). Proportion of tumors associated with estrogen receptor (ER), progestogen receptor (PR) and carcinoembryonic antigen (CEA) expression in blood type A was significantly higher than in other blood types (P = 0.002 for ER expression, 0.009 for PR expression, 0.003 for CEA expression). Proportion of tumors associated with serum CEA and CA19-9 elevation in blood type AB was significantly lower than in other blood types (P < 0.001 for serum CEA elevation, 0.005 for CA19-9 elevation). Though there was no significant difference between ABO blood groups and survival of the patients, patients with blood group B had a trend to show superiority in the survival. The significance of ABO blood group distribution might be associated with biological behavior of gastric adenocarcinoma patients. However, it was found not to be a prognosis factor for patients with gastric adenocarcinoma.

show abstract

Section: Discussioncontrasting

confidence: 90%

A relationship between ABO blood groups and clinicopathologic characteristics of patients with gastric adenocarcinoma in China

et al. 2010

View full text Add to dashboard Cite

show abstract

“…We also found 2 studies provided data on liver cancer, oral cavity cancer (Akhtar et al, 2011;Jaleel et al, 2012), endometrial cancer (Xu et al, 2011;Yuzhalin et al, 2012), bronchogenic cancer (AIRD et al, 1954;Roots et al, 1988), melanoma (Xie et al, 2010;de Giorgi et al, 2011), and leukemia (MACMAHON et al, 1958;Newell et al, 1974). Moreover, 1 study were found for each of the following cancer sites: biliary (Gong et al, 2012), other gynaecological (KROKFORS et al, 1954), tongue (Hartmann et al, 1964), lip (Hartmann et al, 1964), Burkitt's tumour (Williams et al, 1966), glioma (Gong et al, 2012), brain (Pearce et al, 1965), central nervous (Akhtar et al, 2011), salivary gland (OSBORNE et al, 1962), thyroid (Gong et al, 2012), bladder (Llopis et al, 1990), kidney (Joh et al, 2012), bone (Akhtar et al, 2011), mesothelioma (Utkan et al, 2013), and multiple cancer unspecified (Holley et al, 1966). The blood groups were detected using routine clinical tests in most of the studies, and only seven studies acquired the information from blood bank records or questionnaires.…”

Section: Study Characteristicsmentioning

confidence: 55%

“…Some studies included multiple cancer sites, and we analyzed these data separately by site, and the total number of studies by site is 123. Among these studies, we identified 36 studies reported results on gastric cancer (AIRD et al, 1953;AIRD et al, 1954;BILLINGTON, 1956;BUCKWALTER et al, 1958;EISENBERG et al, 1958;MACMAHON et al, 1958;BIRNBAUM et al, 1959;BEASLEY et al, 1960;DOLL et al, 1960;BECKMAN et al, 1961;COTTER et al, 1961;NEWMAN et al, 1961;Hartmann et al, 1964;LISKER et al, 1964;Hoskins et al, 1965;Macafee et al, 1967;Glober et al, 1971;van Wayjen et al, 1973;Newell et al, 1974;Akumabor et al, 1986;Kurtenkov et al, 1995;Klaamas et al, 1999;Su et al, 2001;Kamlesh et al, 2005;El et al, 2007;Edgren et al, 2010;Akhtar et al, 2010;Qiu et al, 2011;Gong et al, 2012;Song et al, 2013), 13 studies on pancreatic cancer (AIRD et al, 1960;Newell et al, 1974;Annese et al, 1990;Wolpin et al, 2009;Greer et al, 2010;Wolpin et al, 2010;Ben et al, 2011;Engin et al, 2012;…”

Section: Study Characteristicsmentioning

confidence: 99%

ABO Blood Groups and Risk of Cancer: a Systematic Review and Meta-analysis

Zhang¹,

He²,

Yu³

et al. 2014

Asian Pacific Journal of Cancer Prevention

120

121

View full text Add to dashboard Cite

Background: For decades, studies have been performed to evaluate the association between ABO blood groups and risk of cancer. However, whether ABO blood groups are associated with overall cancer risk remains unclear. We therefore conducted a meta-analysis of observational studies to assess this association. Materials and Methods: A search of Pubmed, Embase, ScienceDirect, Wiley, and Web of Knowledge databases (to May 2013) was supplemented by manual searches of bibliographies of key retrieved articles and relevant reviews. We included case-control studies and cohort studies with more than 100 cancer cases. Results: The search yielded 89 eligible studies that reported 100,554 cases at 30 cancer sites. For overall cancer risk, the pooled OR was 1.12 (95%CI: between ABO blood groups and overall cancer risk still remains unclear. Therefore, we conducted a systematic review and meta-analysis to evaluate the association between ABO blood groups and overall cancer risk, as well as the risk of individual cancer sites.1 Materials and Methods Search strategyWe performed a systematic literature search (up to May 2013) of Pubmed, Embase, ScienceDirect, Wiley, and Web of Knowledge for studies reporting the association between ABO blood groups (self-reported or lab tested) and cancer risk. In addition, we searched the reference lists of relevant articles and reviews. Only articles published in English were considered. Two search themes were combined using the Boolean operator 'and'. The first theme, cancer, combined exploded versions of the Medical Subject Headings (MeSH) cancer, tumor, carcinoma, neoplasm or malignancy. The second theme, blood group, combined exploded versions of MeSH terms blood group, or blood type.

show abstract

“…And the hand search identified additional five articles. Eventually, 11 studies plus our case-control study were included in the final meta-analysis, with a total sample size of 225,796 subjects [12,16,[24][25][26][27][28][29][30][31][32]. The characteristics of selected studies were described in Table S2.…”

Section: Literature Search and Study Characteristicsmentioning

confidence: 99%

“…All of the eligible studies comprised a total of 13,413 cases and 212,356 controls, and ranged from 112 to 63,346 subjects in each report. The articles were conducted in the following regions: Asia (n = 6) [12,[29][30][31][32] and Europe (n = 6) [16,[24][25][26][27][28]. The majority of included articles were population-based studies (n = 9) [24-29, 31, 32].…”

Section: Literature Search and Study Characteristicsmentioning

confidence: 99%